Comments for: Studies back maligned MS drug

Studies back maligned MS drug
NEW YORK – A promising multiple sclerosis drug that was suspended from the market because three people developed a rare brain disease now appears relatively safe and quite effective, three studies found. The research in Thursday’s New England Journal of Medicine comes days before government… Read More
      Read more

      You may also like

      By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.